According to the latest data from the Hong Kong Stock Exchange, on December 30, J.P. Morgan increased its holding in Pharmaron (03759) by 1,456,225 shares. The transaction was executed at a price of HK$19.388 per share, resulting in a total consideration of approximately HK$28.2333 million. Following this acquisition, J.P. Morgan's latest shareholding amounts to approximately 15.8103 million shares, representing a stake of 5.24%.